Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School ...

Dosimetry is integral to informed implementation of radiopharmaceutical therapies, enabling personalized treatment planning ...

Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...

Objectives [11C]PBB3 is a novel tau imaging PET ligand capable of visualizing tau deposition in Alzheimer’s disease (AD) and non-AD tauopathies. The aim of the present study was to investigate ...

Objectives PET/CT imaging is a diagnostic tool that is used for cancer detection and treatment evaluation. Stability of background FDG uptake in normal tissue is important for verifying that a PET ...

Radiologic imaging is claimed to carry an iatrogenic risk of cancer, based on an uninformed commitment to the 70-y-old linear no-threshold hypothesis (LNTH). Credible evidence of imaging-related ...

Optical techniques, such as bioluminescence and fluorescence, are emerging as powerful new modalities for molecular imaging in disease and therapy. Combining innovative molecular biology and chemistry ...

A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18 F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism ...

Journal of Nuclear Medicine January 2025, jnumed.124.268425; DOI: https://doi.org/10.2967/jnumed.124.268425 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268695; DOI: https://doi.org/10.2967/jnumed.124.268695 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268520; DOI: https://doi.org/10.2967/jnumed.124.268520 ...

Reagents and antibodies were from Sigma-Aldrich, Roche, Invitrogen, R&D Systems, Santa Cruz Biotech, or Merck-Millipore. [U-14 C]-2-deoxyglucose (9,250 kBq [250 μCi]/mmol) was from New England Nuclear ...